Cargando…
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
ABSTRACT: BACKGROUND: As the number of elderly persons increases, neurodegenerative diseases are becoming ubiquitous. There is currently a great need for knowledge concerning management of old-age neurodegenerative diseases; the most important of which are: Alzheimer’s disease, Parkinson’s disease,...
Autores principales: | Sehgal, Sheikh Arslan, Hammad, Mirza A., Tahir, Rana Adnan, Akram, Hafiza Nisha, Ahmad, Faheem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080102/ https://www.ncbi.nlm.nih.gov/pubmed/29542412 http://dx.doi.org/10.2174/1570159X16666180315142137 |
Ejemplares similares
-
In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1
por: Tahir, Rana Adnan, et al.
Publicado: (2020) -
Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening
por: Waqas, Muhammad, et al.
Publicado: (2021) -
Tumor necrosis factor receptor superfamily 10B (TNFRSF10B): an insight from structure modeling to virtual screening for designing drug against head and neck cancer
por: Tahir, Rana Adnan, et al.
Publicado: (2013) -
Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8
por: Sehgal, Sheikh Arslan, et al.
Publicado: (2016) -
Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
por: Schiavone, Stefania, et al.
Publicado: (2018)